Whether that difference justifies the price increase depends on your individual response and goals
While the European Medicines Agency (EMA) classifies this as a very rare adverse reaction, the increased relative risk particularly in patients with type 2 diabetes or obesity has prompted updates to drug product information
Therefore, patients with inadequate or no insurance coverage may have affordability concerns
Mendis, B., Simpson, E., MacDonald, I
Benefits of PT-141 Peptide Therapy Rapid increase in sexual desireeffects often begin within 3060 minutes Supports both spontaneous and responsive intimacy Does not alter hormone levels or cardiovascular function Convenient, on-demand use Can be used by both women and men Supports confidence, connection, and quality of life Who Can Benefit from PT-141
And as always, the patient's expectations should be calibrated to what the evidence actually supports